Safety evaluation of Eugenia jambolana seed extract

Jayanta M. Sankhari, Ravirajsinh N. Jadeja, Menaka C. Thounaojam, Ranjitsinh V. Devkar, Ramachandran AV

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Objective: To evaluate the safety of ethanolic seed extract of Eugenia jambolana (EJSE) using acute and sub-chronic toxicity assays in Swiss albino mice as per Organisation for Economic Co-operation and Development (OECD) guidelines. Methods: Possible behavioral changes and lethality were observed in mice administered a single dose [1 000, 2 000, 3 000, 4 000 or 5 000 mg/kg body weight (BW)] of EJSE. Plasma levels of metabolic, hepatic, cardiac and renal function markers, electrolytes, blood count and histopathology of major organs were monitored in mice chronically treated with EJSE (1 000, 2 000 or 3 000 mg/kg BW) for 28 days. Results: Since no mortality was recorded in the acute toxicity evaluation up to a dose of 5 000 mg/kg bodyweight of EJSE, 50% lethal dose (LD50) was assumed to be > 5 000 mg/kg BW. In the sub-chronic toxicity evaluation, no adverse observations were recorded in mice administered with 2 000 mg/kg BW of EJSE; however at 3 000 mg/kg BW dose, moderately significant increase in the plasma levels of urea and creatinine was observed. Hence, the lowest observable adverse effect level (LOAEL) for EJSE was found to be 3 000 mg/kg BW and the no observable adverse effect level (NOAEL) was adjudged as 2 000 mg/kg BW. Conclusions: It can be concluded from this study that, orally administered EJSE is safe up to a 10 fold higher dose than its reported therapeutic dose.

Original languageEnglish (US)
Pages (from-to)982-987
Number of pages6
JournalAsian Pacific Journal of Tropical Medicine
Volume3
Issue number12
DOIs
StatePublished - Dec 1 2010

Fingerprint

Syzygium
Seeds
Body Weight
Safety
Lethal Dose 50
Electrolytes
Urea
Creatinine
Guidelines
Kidney
Mortality
Liver

Keywords

  • Acute toxicity
  • Eugenia jambolana
  • LOAEL
  • NOAEL
  • Sub chronic toxicity

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Safety evaluation of Eugenia jambolana seed extract. / Sankhari, Jayanta M.; Jadeja, Ravirajsinh N.; Thounaojam, Menaka C.; Devkar, Ranjitsinh V.; AV, Ramachandran.

In: Asian Pacific Journal of Tropical Medicine, Vol. 3, No. 12, 01.12.2010, p. 982-987.

Research output: Contribution to journalArticle

Sankhari, Jayanta M. ; Jadeja, Ravirajsinh N. ; Thounaojam, Menaka C. ; Devkar, Ranjitsinh V. ; AV, Ramachandran. / Safety evaluation of Eugenia jambolana seed extract. In: Asian Pacific Journal of Tropical Medicine. 2010 ; Vol. 3, No. 12. pp. 982-987.
@article{5a5abaec7fd74c628feec60644938563,
title = "Safety evaluation of Eugenia jambolana seed extract",
abstract = "Objective: To evaluate the safety of ethanolic seed extract of Eugenia jambolana (EJSE) using acute and sub-chronic toxicity assays in Swiss albino mice as per Organisation for Economic Co-operation and Development (OECD) guidelines. Methods: Possible behavioral changes and lethality were observed in mice administered a single dose [1 000, 2 000, 3 000, 4 000 or 5 000 mg/kg body weight (BW)] of EJSE. Plasma levels of metabolic, hepatic, cardiac and renal function markers, electrolytes, blood count and histopathology of major organs were monitored in mice chronically treated with EJSE (1 000, 2 000 or 3 000 mg/kg BW) for 28 days. Results: Since no mortality was recorded in the acute toxicity evaluation up to a dose of 5 000 mg/kg bodyweight of EJSE, 50{\%} lethal dose (LD50) was assumed to be > 5 000 mg/kg BW. In the sub-chronic toxicity evaluation, no adverse observations were recorded in mice administered with 2 000 mg/kg BW of EJSE; however at 3 000 mg/kg BW dose, moderately significant increase in the plasma levels of urea and creatinine was observed. Hence, the lowest observable adverse effect level (LOAEL) for EJSE was found to be 3 000 mg/kg BW and the no observable adverse effect level (NOAEL) was adjudged as 2 000 mg/kg BW. Conclusions: It can be concluded from this study that, orally administered EJSE is safe up to a 10 fold higher dose than its reported therapeutic dose.",
keywords = "Acute toxicity, Eugenia jambolana, LOAEL, NOAEL, Sub chronic toxicity",
author = "Sankhari, {Jayanta M.} and Jadeja, {Ravirajsinh N.} and Thounaojam, {Menaka C.} and Devkar, {Ranjitsinh V.} and Ramachandran AV",
year = "2010",
month = "12",
day = "1",
doi = "10.1016/S1995-7645(11)60014-X",
language = "English (US)",
volume = "3",
pages = "982--987",
journal = "Asian Pacific Journal of Tropical Medicine",
issn = "1995-7645",
publisher = "Elsevier (Singapore) Pte Ltd",
number = "12",

}

TY - JOUR

T1 - Safety evaluation of Eugenia jambolana seed extract

AU - Sankhari, Jayanta M.

AU - Jadeja, Ravirajsinh N.

AU - Thounaojam, Menaka C.

AU - Devkar, Ranjitsinh V.

AU - AV, Ramachandran

PY - 2010/12/1

Y1 - 2010/12/1

N2 - Objective: To evaluate the safety of ethanolic seed extract of Eugenia jambolana (EJSE) using acute and sub-chronic toxicity assays in Swiss albino mice as per Organisation for Economic Co-operation and Development (OECD) guidelines. Methods: Possible behavioral changes and lethality were observed in mice administered a single dose [1 000, 2 000, 3 000, 4 000 or 5 000 mg/kg body weight (BW)] of EJSE. Plasma levels of metabolic, hepatic, cardiac and renal function markers, electrolytes, blood count and histopathology of major organs were monitored in mice chronically treated with EJSE (1 000, 2 000 or 3 000 mg/kg BW) for 28 days. Results: Since no mortality was recorded in the acute toxicity evaluation up to a dose of 5 000 mg/kg bodyweight of EJSE, 50% lethal dose (LD50) was assumed to be > 5 000 mg/kg BW. In the sub-chronic toxicity evaluation, no adverse observations were recorded in mice administered with 2 000 mg/kg BW of EJSE; however at 3 000 mg/kg BW dose, moderately significant increase in the plasma levels of urea and creatinine was observed. Hence, the lowest observable adverse effect level (LOAEL) for EJSE was found to be 3 000 mg/kg BW and the no observable adverse effect level (NOAEL) was adjudged as 2 000 mg/kg BW. Conclusions: It can be concluded from this study that, orally administered EJSE is safe up to a 10 fold higher dose than its reported therapeutic dose.

AB - Objective: To evaluate the safety of ethanolic seed extract of Eugenia jambolana (EJSE) using acute and sub-chronic toxicity assays in Swiss albino mice as per Organisation for Economic Co-operation and Development (OECD) guidelines. Methods: Possible behavioral changes and lethality were observed in mice administered a single dose [1 000, 2 000, 3 000, 4 000 or 5 000 mg/kg body weight (BW)] of EJSE. Plasma levels of metabolic, hepatic, cardiac and renal function markers, electrolytes, blood count and histopathology of major organs were monitored in mice chronically treated with EJSE (1 000, 2 000 or 3 000 mg/kg BW) for 28 days. Results: Since no mortality was recorded in the acute toxicity evaluation up to a dose of 5 000 mg/kg bodyweight of EJSE, 50% lethal dose (LD50) was assumed to be > 5 000 mg/kg BW. In the sub-chronic toxicity evaluation, no adverse observations were recorded in mice administered with 2 000 mg/kg BW of EJSE; however at 3 000 mg/kg BW dose, moderately significant increase in the plasma levels of urea and creatinine was observed. Hence, the lowest observable adverse effect level (LOAEL) for EJSE was found to be 3 000 mg/kg BW and the no observable adverse effect level (NOAEL) was adjudged as 2 000 mg/kg BW. Conclusions: It can be concluded from this study that, orally administered EJSE is safe up to a 10 fold higher dose than its reported therapeutic dose.

KW - Acute toxicity

KW - Eugenia jambolana

KW - LOAEL

KW - NOAEL

KW - Sub chronic toxicity

UR - http://www.scopus.com/inward/record.url?scp=78651439539&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78651439539&partnerID=8YFLogxK

U2 - 10.1016/S1995-7645(11)60014-X

DO - 10.1016/S1995-7645(11)60014-X

M3 - Article

AN - SCOPUS:78651439539

VL - 3

SP - 982

EP - 987

JO - Asian Pacific Journal of Tropical Medicine

JF - Asian Pacific Journal of Tropical Medicine

SN - 1995-7645

IS - 12

ER -